Latest news
Minerva Neurosciences (NASDAQ: NERV) logs $107.9M loss but holds $75.4M cash - Stock TitanStock Titan · Fri, 07 Aug 2026 11:31:14 GMTNERV: Adjusted net loss widened as R&D and G&A costs rose, with Phase 3 data expected in 2H 2027 - TradingViewTradingView · Fri, 07 Aug 2026 11:22:10 GMTMinerva Neurosciences (Nasdaq: NERV) swings to Q2 profit on warrant gain - Stock TitanStock Titan · Fri, 07 Aug 2026 11:14:09 GMTMinerva's schizophrenia trial is designed to enroll 380 patients - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTMinerva Neurosciences (NERV) awards options tied to Phase 3 trial - Stock TitanStock Titan · Mon, 03 Aug 2026 22:05:46 GMTNERV Q2'26 Earnings: EPS estimate is (0.19) USD - TradingViewTradingView · Mon, 03 Aug 2026 11:01:15 GMTJapan's NERV: An evacuation order has been issued to 8,012 households (17,477 people) in Tamana City, Kumamoto Prefecture - news.cgtn.comnews.cgtn.com · Tue, 28 Jul 2026 07:00:00 GMT